Clinical trial
MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in…
NCT00430352 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00430352 |
|---|---|
| Title | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. |
| Official title | A Study to Evaluate the Safety of MabThera (Rituximab) Maintenance Therapy in Patients With Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | rituximab [MabThera/Rituxan] |
| Enrollment | 545 |
| Start date | Sep 4, 2006 |
| Primary completion | May 26, 2011 |
| Completion | May 26, 2011 |
| First posted | Feb 1, 2007 |
| Last update posted | Aug 14, 2017 |
| Countries | Albania, Argentina, Australia, Bosnia and Herzegovina, Brazil, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Germany and 12 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: